CDTI NEOTEC Program Spain 2026

NEOTEC grants target Spanish technology-based startups less than 3 years old at the time of application. The company must have an innovative technology-based business model, be registered as a Sociedad Limitada or Sociedad Anonima in Spain, and have the technical team to execute the proposed project. NEOTEC provides non-repayable grants of up to EUR 250,000 to cover business plan development and initial technology development activities.

NEOTEC covers personnel costs, equipment and materials, external consulting, patent filing, and other costs directly related to executing the startup's business plan. CDTI typically opens one call per year, usually in the spring, with a submission window of several weeks. The evaluation process takes approximately 4 to 6 months. Applicants should prepare detailed technical and financial plans well in advance of the call opening date.

NEOTEC exclusively targets tech startups under three years old with non-repayable grants. Unlike ENISA's repayable participative loans, NEOTEC provides equity-free capital for business plan execution during critical formation. National scope and substantial individual amounts position it as Spain's premier instrument for deep technology ventures needing significant upfront capital before revenue generation.

Beneficiaries submit technical and financial progress reports documenting expenditure against budget lines. They demonstrate advancement toward milestones and business objectives. CDTI may conduct site visits requesting invoices, contracts, and IP certificates. Significant plan deviations require prior authorization. Failing minimum execution thresholds triggers proportional reductions or reimbursement demands.

NEOTEC evaluation panels assess CSIC spinoff proposals examining technology transfer agreement completeness, background intellectual property licensing clarity, and researcher-founder transition commitment documentation. Laboratory-to-market translation plans must demonstrate manufacturing scalability pathways beyond bench-scale synthesis procedures. Prototype characterization data including material purity certifications, performance degradation testing results, and accelerated aging simulation outcomes substantiate technical readiness assertions. Commercialization timelines benchmarking competitor product development trajectories and anticipated regulatory approval durations provide market entry realism assessment frameworks for evaluation committee deliberation.

NEOTEC participative loan instruments provide subordinated debt positioning with equity-linked return mechanisms rather than requiring immediate equity dilution through share issuance. Founders preserve capitalization table simplicity during pre-revenue development phases when valuation uncertainty makes equity pricing contentious. Variable interest components indexed to revenue achievement milestones align CDTI returns with commercial success realization. Conversion option provisions enable future equity participation under predetermined valuation methodologies should venture performance warrant additional institutional capital participation. These hybrid characteristics attract founders reluctant to accept aggressive liquidation preference hierarchies imposed by conventional venture capital term sheets.